These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 1341911)
1. Pathogeny and immunological control of toxoplasmosis. Derouin F Braz J Med Biol Res; 1992; 25(12):1163-9. PubMed ID: 1341911 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Toxoplasma gondii persistence and latency. Sullivan WJ; Jeffers V FEMS Microbiol Rev; 2012 May; 36(3):717-33. PubMed ID: 22091606 [TBL] [Abstract][Full Text] [Related]
4. Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections. Pittman KJ; Knoll LJ Microbiol Mol Biol Rev; 2015 Dec; 79(4):387-401. PubMed ID: 26335719 [TBL] [Abstract][Full Text] [Related]
5. Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine. Kim SK; Karasov A; Boothroyd JC Infect Immun; 2007 Apr; 75(4):1626-34. PubMed ID: 17261600 [TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Yap GS; Sher A Immunobiology; 1999 Dec; 201(2):240-7. PubMed ID: 10631573 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. Gazzinelli R; Xu Y; Hieny S; Cheever A; Sher A J Immunol; 1992 Jul; 149(1):175-80. PubMed ID: 1351500 [TBL] [Abstract][Full Text] [Related]
8. Toxoplasmosis: comparative species susceptibility and host immune response. Innes EA Comp Immunol Microbiol Infect Dis; 1997 Feb; 20(2):131-8. PubMed ID: 9208198 [TBL] [Abstract][Full Text] [Related]
9. Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of Sa Q; Ochiai E; Tiwari A; Mullins J; Shastri N; Mercier C; Cesbron-Delauw MF; Suzuki Y J Immunol; 2017 Jun; 198(11):4425-4434. PubMed ID: 28446567 [No Abstract] [Full Text] [Related]
10. [Toxoplasma gondii: perspectives for a vaccine]. Gottstein B Schweiz Med Wochenschr Suppl; 1995; 65():89S-95S. PubMed ID: 7716458 [TBL] [Abstract][Full Text] [Related]
11. [Toxoplasma gondii: a potential role in the genesis of psychiatric disorders]. Fond G; Capdevielle D; Macgregor A; Attal J; Larue A; Brittner M; Ducasse D; Boulenger JP Encephale; 2013 Feb; 39(1):38-43. PubMed ID: 23095600 [TBL] [Abstract][Full Text] [Related]
12. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979 [TBL] [Abstract][Full Text] [Related]
13. Characterization of tachyzoite and bradyzoite antigens of Toxoplasma gondii recognized by immunoglobulins G, M and A in an experimental model of reactivated toxoplasmosis. el-Shennawy SF; el-Gozamy BM; Mahmoud MS; Thabet HS J Egypt Soc Parasitol; 2000 Aug; 30(2):349-64. PubMed ID: 10946497 [TBL] [Abstract][Full Text] [Related]
14. TGF-β1 levels and intraocular tissue alterations in mice infected with a virulent type I RH Toxoplasma gondii strain. Iqbal J; Al-Awadhi MA; Raghupathy RG Exp Parasitol; 2016 Mar; 162():57-63. PubMed ID: 26773166 [TBL] [Abstract][Full Text] [Related]